Enanta-Med, Testosterone Enanthate, 300 mg/ml, 10 ml

Testosterone Enanthate 300 mg/ml by Bioniche Pharma is a long-acting parenteral androgenic formulation containing an esterified variant of endogenous testosterone. Engineered by Bioniche Pharma in a high-grade oil vehicle for deep intramuscular delivery, Bioniche Pharma Testosterone Enanthate provides sustained systemic clearance to correct endogenous androgen deficiencies and preserve androgen-dependent physiological functions.

CLINICAL PHARMACOLOGY & MECHANISM OF ACTION

Testosterone Enanthate by Bioniche Pharma operates by binding with high affinity to intracellular nuclear androgen receptors, driving skeletal muscle protein translation and promoting cellular nitrogen conservation. By maintaining physiological circulating hormone levels, Bioniche Pharma Testosterone Enanthate supports bone mineral density, stimulates red blood cell synthesis, and preserves secondary male sexual characteristics while modulating pituitary gonadotropin output through feedback mechanism regulation.

INDICATIONS & CLINICAL USE

• Male Androgen Replacement Therapy: Treatment of primary hypogonadism secondary to testicular dysfunction (orchitis, cryptorchidism, vanishing testis syndrome, bilateral torsion, or orchidectomy) and hypogonadotropic hypogonadism caused by hypothalamic-pituitary lesions or isolated gonadotropin deficiency using Bioniche Pharma Testosterone Enanthate.
• Delayed Male Puberty: Induction of pubertal maturation in carefully selected adolescent males with confirmed constitutional growth delay.
• Female Palliative Oncology: Adjunctive palliative treatment for progressive inoperable metastatic breast carcinoma in women 1 to 5 years postmenopausal, or premenopausal female patients with hormone-sensitive breast cancer who previously responded to oophorectomy.

CONTRAINDICATIONS

• Male patients with diagnosed or suspected prostate carcinoma or male breast cancer.
• Pregnancy, planned pregnancy, and lactation due to high risks of female fetal virilization (including clitoromegaly, urogenital fold fusion, and structural malformations).
• Known hypersensitivity or allergic response to Testosterone Enanthate, vehicle oils, or compounding ingredients in Bioniche Pharma injectables.

DRUG INTERACTIONS

• Oral Anticoagulants: Concurrent administration of exogenous androgens with oral anticoagulants (such as coumarin derivatives) can decrease anticoagulant dosage needs. Patients on blood thinners during Bioniche Pharma Testosterone Enanthate therapy require frequent prothrombin time (PT/INR) testing, especially during treatment initiation or withdrawal.

PRECAUTIONS & CLINICAL MONITORS

• Virilization Surveillance in Females: Female patients receiving Bioniche Pharma Testosterone Enanthate should be routinely monitored for virilizing features (hirsutism, voice deepening, acne, menstrual irregularity). Immediate clinical evaluation is required if signs develop.
• Cardiovascular & Lipid Management: Exogenous androgens can shift serum lipid levels (reducing HDL and increasing LDL cholesterol). Close clinical monitoring is advised for patients with existing coronary artery disease, prior myocardial infarction, or cardiovascular risk factors.
• General Clinical Signs: Patients should report any gastrointestinal distress (nausea, vomiting), changes in skin tone, or peripheral fluid retention (ankle swelling) to their physician promptly.

DOSAGE & ADMINISTRATION

Testosterone Enanthate by Bioniche Pharma is formulated exclusively for deep intramuscular injection. Dosing regimens must be tailored based on diagnosis, age, skeletal maturity, and lab parameters:

• Hypogonadism Replacement: Standard therapeutic protocols range from 200 mg to 600 mg of Bioniche Pharma Testosterone Enanthate administered every 2 to 3 weeks under clinical supervision.
• Delayed Male Puberty: Typical dosages range between 50 mg and 200 mg given every 2 to 4 weeks for a short duration (usually 4 to 6 months), supported by routine skeletal age radiographies.
• Female Metastatic Mammary Cancer: Dosing schedules are managed strictly by an oncologist, generally involving 200 mg to 400 mg every 2 to 4 weeks.

STORAGE & HANDLING

Store Bioniche Pharma Testosterone Enanthate in a dry, cool location shielded from direct sunlight exposure and elevated heat. Do not refrigerate or freeze. Store strictly out of the reach and sight of children.